A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

GLP-1 supplements are advertised as a cheaper alternative to weight loss with Ozempic or Wegovy. Doctors explain if they help ...

F ROM LOS ANGELES to London, weight-loss drugs such as Ozempic are reshaping culture as much as waistlines. Some ...

Dietary supplements are a $380 billion industry worldwide, but it’s hard to know which ones we truly need, especially during ...

While the link between diabetes and periodontal disease is known, the impact of diabetes treatment on periodontal health is ...

And research suggests omega-3 fatty acids and magnesium may offer a protective benefit, lowering a person's risk of type 2 ...

Injectable prescription drugs that reduce appetite — like Ozempic, Saxenda and Mounjaro — have skyrocketed in popularity in ...

Balance your blood sugar naturally with Sugar Defender’s blend of powerful ingredients for optimal glucose control and energy ...

Eli Lilly, the makers of tirzepatide—which they sell as Mounjaro for diabetes and Zepbound for weight loss— announced ...

The demand for weight loss medications are on the rise, and now, “natural” GLP-1s are being marketed to help you lose weight.

Scientists in China have found evidence in monkeys that metformin can reliably slow down the brain's aging process.

People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the ...